Selenium restores defective beta-adrenergic receptor response of thoracic aorta in diabetic rats

Molecular and Cellular Biochemistry

Volumn 338, Issue 1-2, 2010, Pages 191-201

  Zeydanli, Esma N ^a   Bilginoglu, Ayca ^a   Tanriverdi, Evrim ^a   Gurdal, Hakan ^a   Turan, Belma ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Beta adrenergic receptors; Diabetes; Endothelin; Matrix metalloproteinase; Oxidative stress; Protein kinase C; Selenium

Indexed keywords

BETA ADRENERGIC RECEPTOR; GELATINASE A; SELENATE; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; GLUCOSE BLOOD LEVEL; ISOPRENALINE; MATRIX METALLOPROTEINASE; NITRITE; SELENIC ACID; SELENIUM DERIVATIVE; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA CONSTRICTION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME REGULATION; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; RAT; SMOOTH MUSCLE FIBER; THORACIC AORTA; TISSUE HOMOGENATE; ZYMOGRAPHY; ANIMAL; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; WISTAR RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; BLOOD GLUCOSE; CYCLIC AMP; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; ISOPROTERENOL; MALE; MATRIX METALLOPROTEINASES; NITRITES; OXIDATIVE STRESS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; SELENIUM COMPOUNDS; SULFHYDRYL COMPOUNDS; VASOCONSTRICTION; VASODILATION; SELENIC ACID;

RATTUS;

EID: 77951298114     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0353-5     Document Type: Article

References (37)

1. I Björkhem A Henriksson-Freyschuss O Breuer U Diczfalusy L Berglund P Henriksson 1991 The antioxidant butylated hydroxytoluene protects against atherosclerosis Arterioscler Thromb 11 15 22 1987993
2. X Lu S Liu RY Man 1994 Enhancement of endothelium dependent relaxation in the rat aortic ring by selenium supplement Cardiovasc Res 28 345 348 10.1093/cvr/28.3.345 1:CAS:528:DyaK2cXkvVWlsrw%3D 8174154
3. RF Furchgott PM Vanhoutt 1989 Endothelium-derived relaxing and contracting factors FASEB J 3 2007 2018 1:CAS:528:DyaL1MXkslGiu74%3D 2545495
4. JG Hardman 1984 Cyclic nucleotides and regulation of vascular smooth muscle J Cardiovasc Pharmacol 6 639 645 10.1097/00005344-198406004-00010 1:CAS:528:DyaL2MXhslOitw%3D%3D
5. SM Son 2007 Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes Diabetes Res Clin Prac 77 65 70 10.1016/j.diabres.2007.01.036 (Pubitemid 47212556)
6. CM Dollery JR McEwan AM Henney 1995 Matrix metalloproteinases and cardiovascular disease Circ Res 77 863 868 1:CAS:528:DyaK2MXovVKrt7s%3D 7554139
7. GA Limb K Matter G Murphy AD Cambrey PN Bishop GE Morris PT Khaw 2005 Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis Am J Pathol 166 1555 1563 1:CAS:528:DC%2BD2MXksFGmtbc%3D 15855654
8. MC Pustovrh A Jawerbaum E Capobianco V White N Martínez JJ López-Costa E González 2005 Oxidative stress promotes the increase of matrix metalloproteinases-2 and -9 activities in the feto-placental unit of diabetic rats Free Radic Res 39 1285 1293 10.1080/10715760500188796 1:CAS:528:DC%2BD2MXht1eltL3I 16298858 (Pubitemid 43023793)
9. KS Moshal N Metreveli SC Tyagi 2008 Mitochondrial matrix metalloproteinase activation and dysfunction in hyperhomocysteinemia Curr Vasc Pharmacol 6 84 92 10.2174/157016108783955301 1:CAS:528:DC%2BD1cXkt1alsLk%3D 18393909
10. JH McNeill HL Delgatty ML Battell 1991 Insulin like effects of sodium selenate in streptozocin-induced diabetic rats Diabetes 40 1675 1678 10.2337/diabetes.40.12.1675 1:CAS:528:DyaK38XjsVehsg%3D%3D 1756907
11. M Ayaz B Can S Ozdemir B Turan 2002 Protective effect of selenium treatment on diabetes-induced myocardial structural alterations Biol Trace Elem Res 89 215 226 10.1385/BTER:89:3:215 1:CAS:528:DC%2BD38XptVyitrw%3D 12462745 (Pubitemid 35335237)
12. G Ersöz A YakaryIlmaz B Turan 2003 Effect of antioxidant treatment on platelet aggregation of streptozotocin-induced diabetic rats Thromb Res 111 363 367 10.1016/S0049-3848(03)00338-4 14698654 (Pubitemid 38032903)
13. A Kiersztan A Baranska M Hapka M Lebiedzinska K Winiarska M Dudziak J Bryla 2009 Differential action of methylselenocysteine in control and alloxan-diabetic rabbits Chem Biol Interact 177 161 171 10.1016/j.cbi.2008.10. 022 1:CAS:528:DC%2BD1cXhsFagurnE 19010315
14. P Chew DY Yuen P Koh N Stefanovic MA Febbraio I Kola ME Cooper JB de Haan 2009 Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse Arterioscler Thromb Vasc Biol 29 823 830 10.1161/ATVBAHA.109.186619 1:CAS:528:DC%2BD1MXlslCns7w%3D 19325139
15. N Yaras M Sariahmetoglu A Bilginoglu A Aydemir-Koksoy A Onay-Besikci B Turan R Schulz 2008 Protective action of doxycycline against diabetic cardiomyopathy in rats Br J Pharmacol 155 1174 1184 10.1038/bjp.2008.373 1:CAS:528:DC%2BD1cXhsVKlt73I 18806806
16. H Gurdal A Can M Ugur 2005 The role of nitric oxide synthase in reduced vasocontractile responsiveness induced by prolonged alpha 1-adrenergic receptor stimulation in rat thoracic aorta Br J Pharmacol 145 203 210 10.1038/sj.bjp.0706177 15753950 (Pubitemid 40756524)
17. CQ Gao G Sawicki WL Suarez-Pinzon T Cson M Wozniak P Ferdinandy R Schulz 2003 Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction Cardiovasc Res 57 426 433 10.1016/S0008-6363(02)00719-8 1:CAS:528:DC%2BD3sXptFCnsw%3D%3D 12566115 (Pubitemid 36144221)
18. B Tunctan O Uludag S Altug N Abacioglu 1998 Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice Pharmacol Res 38 405 411 10.1006/phrs.1998.0381 1:CAS:528:DyaK1MXmtVWq 9806822 (Pubitemid 28515514)
19. A Bilginoglu A Seymen E Tuncay E Zeydanli A Aydemir-Koksoy B Turan 2009 Antioxidants but not doxycycline treatments restore depressed beta-adrenergic responses of the heart in diabetic rats Cardiovasc Toxicol 9 21 29 10.1007/s12012-009-9032-8 1:CAS:528:DC%2BD1MXkt1yhu7g%3D 19294534
20. M Yanagisawa H Kurihara S Kimura Y Tomobe M Kobayashi Y Mitsui Y Yazaki K Goto T Masaki 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 411 415 10.1038/332411a0 1:CAS:528: DyaL1cXlsVaks78%3D 2451132 (Pubitemid 18090241)
21. T Inoguchi P Li F Umeda HY Yu M Kakimoto M Imamura T Aoki T Etoh T Hashimoto M Naruse H Sano H Utsumi H Nawata 2000 High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 49 1939 1945 10.2337/diabetes.49.11.1939 1:CAS:528:DC%2BD3cXnvVOmtLo%3D 11078463
22. NN Ulusu B Turan 2005 Beneficial effects of selenium on some enzymes of diabetic rat heart Biol Trace Elem Res 103 207 216 10.1385/BTER:103:3:207 1:CAS:528:DC%2BD2MXktFKmsL0%3D 15784954 (Pubitemid 40628896)
23. K Kamata N Miyata T Abiru Y Kasuya 1992 Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus Life Sci 50 1379 1387 10.1016/0024-3205(92)90256-O 1:CAS:528:DyaK38XitFWqu74%3D 1374144
24. TS Lee KA Saltsman H Ohashi GL King 1989 Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications Proc Natl Acad Sci USA 86 5141 5145 10.1073/pnas.86.13.5141 1:CAS:528:DyaL1MXkvFCrtLg%3D 2740348
25. GM Chisolm D Steinberg 2000 The oxidative modification hypothesis of atherogenesis: an overview Free Radic Biol Med 28 1815 1826 10.1016/S0891- 5849(00)00344-0 1:CAS:528:DC%2BD3cXls1GhsrY%3D 10946223 (Pubitemid 30628668)
26. MP Bendeck M Conte M Zhang N Nili BH Strauss SM Farwell 2002 Doxycycline modulates smooth muscle cell growth, migration and matrix remodeling after arterial injury Am J Pathol 160 3 1089 1095 1:CAS:528:DC%2BD38XisVemtL4%3D 11891205
27. RT Clements NR Sodha J Feng M Boodhwani Y Liu S Mieno KR Khabbaz C Bianchi FW Sellke 2009 Impaired coronary microvascular dilation correlates with enhanced vascular smooth muscle MLC phosphorylation in diabetes Microcirculation 16 193 206 10.1080/10739680802461950 1:CAS:528:DC%2BD1MXpsVyqsA%3D%3D 19152178
28. GN Pierce NS Dhalla 1985 Mechanisms of the defect of cardiac myofibrillar function during diabetes Am J Physiol Endocrinol Metabo 248 E170 E175 1:CAS:528:DyaL2MXht12rsLk%3D
29. S Rajagopalan XP Meng S Ramasamy DG Harrison ZS Galis 1996 Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability J Clin Investig 98 2572 2579 10.1172/JCI119076 1:CAS:528:DyaK28XnsVWnt78%3D 8958220
30. S Uemura H Matsushita W Li AJ Glassford T Asagami KH Lee DG Harrison PS Tsao 2001 Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress Circ Res 88 1291 1298 10.1161/hh1201.092042 1:CAS:528:DC%2BD3MXltFCgsL8%3D 11420306
31. V Portik-Dobos MP Anstadt J Hutchinson M Bannan A Ergul 2002 Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes Diabetes 51 3063 3068 10.2337/diabetes.51.10.3063 1:CAS:528:DC%2BD38XnslGhsLs%3D 12351448
32. MM Elgebaly A Kelly AK Harris H Elewa V Portik-Dobos P Ketsawatsomkron M Marrero A Ergul 2008 Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1 Can J Physiol Pharmacol 86 6 358 364 10.1139/Y08-034 1:CAS:528:DC%2BD1cXnt1Cgsbk%3D 18516099 (Pubitemid 351821129)
33. C Fernandez-Patron KG Stewart Y Zhang E Koivunen MW Radomsk ST Davidge 2000 Vascular matrix metalloproteinase-2 dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction Circ Res 87 670 676 1:CAS:528:DC%2BD3cXoslyjsLg%3D 11029402
34. T Matsumoto T Kobayashi K Kamata 2008 Relationships among ET-1, PPAR, oxidative stress and endothelial dysfunction in diabetic animals J Smooth Muscle Res 44 2 41 55 10.1540/jsmr.44.41 18552452
35. AB Skalska A Pietrzycka M Stepniewski 2009 Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension Clin Biochem 42 358 364 10.1016/j.clinbiochem.2008.11.002 1:CAS:528:DC%2BD1MXivVSjt78%3D 19046960
36. JD Raffetto RA Khalil 2008 Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease Biochem Pharmacol 75 346 359 10.1016/j.bcp.2007.07.004 1:CAS:528:DC%2BD1cXhsVynsg%3D%3D 17678629 (Pubitemid 350298459)
37. P Brenneisen H Steinbrenner H Sies 2005 Selenium, oxidative stress and health aspects Mol Aspects Med 26 256 267 10.1016/j.mam.2005.07.004 1:CAS:528:DC%2BD2MXpslygtbo%3D 16105679 (Pubitemid 41225352)